Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-089018

Options or other derivatives

  • Chief Financial Officer acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mokari Atabak Chief Financial Officer 2026-02-27 Grant or award · Stock Option (right to buy) +140,000 140,000 D
Loading xslF345X05/ownership.xml…